Helicobacter pylori susceptibility to fosfomycin, rifampin, and 5 usual antibiotics for H. pylori eradication

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 3, 2014, Pages 358-361

  Boyanova, Lyudmila ^a   Davidkov, Lubomir ^b   Gergova, Galina ^a   Kandilarov, Naiden ^b   Evstatiev, Ivailo ^b   Panteleeva, Emilia ^c   Mitov, Ivan ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^c University Pediatric Hospital   (Bulgaria)

Author keywords

Antibiotic; Clarithromycin; Fosfomycin; Helicobacter pylori; Levofloxacin; Multidrug; Resistance; Rifampicin; Rifampin

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; FOSFOMYCIN; LEVOFLOXACIN; METRONIDAZOLE; QUINOLONE; RIFAMPICIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; ADOLESCENT; ANTIBIOTIC RESISTANCE; CHILD; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; FEMALE; FOSFOMYCIN; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RIFAMPIN;

EID: 84902086142     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.03.028     Document Type: Article

References (27)

1. Barahona-Garrido J., Quiñonez N.F., Cerda-Contreras E., Maria Sarti H., Téllez-Ávila F.I. Fosfomycin-containing second-line treatment for Helicobacter pylori infection. Am J Gastroenterol 2013, 108:858-859.
2. Best L.M., Haldane D.J., Keelan M., Taylor D.E., Thomson A.B., Loo V., et al. Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob Agents Chemother 2003, 47:3138-3144.
3. Blacky A., Makristathis A., Apfalter P., Willinger B., Rotter M.L., Hirschl A.M. In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole. Eur J Clin Microbiol Infect Dis 2005, 24:276-279.
4. Boyanova L. Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria. J Med Microbiol 2009, 58:930-935.
5. Boyanova L. H. pylori resistance to antibiotics. Helicobacter pylori 2011, 201-235. Caister Academic Press, Norfolk, UK. L. Boyanova (Ed.).
6. Boyanova L., Gergova G., Nikolov R., Davidkov L., Kamburov V., Jelev C., et al. Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods. Diagn Microbiol Infect Dis 2008, 60:409-415.
7. Boyanova L., Nikolov R., Gergova G., Evstatiev I., Lazarova E., Kamburov V., et al. Two-decade trends in primary H. pylori resistance to antibiotics in Bulgaria. Diagn Microbiol Infect Dis 2010, 67:319-326.
8. Cederbrant G., Kahlmeter G., Ljungh A. The E test for antimicrobial susceptibility testing of Helicobacter pylori. J Antimicrob Chemother 1993, 31:65-71.
9. Chisholm S.A., Owen R.J. Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK. J Med Microbiol 2009, 58:1322-1328.
10. De Francesco V., Giorgio F., Hassan C., Manes G., Vannella L., Panella C., et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010, 19:409-414.
11. Gisbert J.P., Calvet X. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 2012, 35:209-221.
12. Glocker E., Stueger H.P., Kist M. Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother 2007, 51:346-349.
13. Graham D.Y., Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010, 59:1143-1153.
14. Hirata K., Suzuki H., Nishizawa T., Tsugawa H., Muraoka H., Saito Y., et al. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J Gastroenterol Hepatol 2010, 25(Suppl 1):S75-S79.
15. Karageorgopoulos D.E., Wang R., Yu X.H., Falagas M.E. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother 2012, 67:255-268.
16. Kim J.M., Kim J.S., Kim N., Kim S.G., Jung H.C., Song I.S. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents 2006, 28:6-13.
17. Liu G., Xu X., He L., Ding Z., Gu Y., Zhang J., et al. Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children. Helicobacter 2011, 16:356-362.
18. Lu C.L., Liu C.Y., Huang Y.T., Liao C.H., Teng L.J., Turnidge J.D., et al. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 2011, 55:4295-4301.
19. Malfertheiner P., Megraud F., O'Morain C.A., Atherton J., Axon A.T., Bazzoli F., et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012, 61:646-664. European Helicobacter Study Group.
20. Miehlke S., Hansky K., Schneider-Brachert W., Kirsch C., Morgner A., Madisch A., et al. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Aliment Pharmacol Ther 2006, 24:395-403.
21. Milani M., Ghotaslou R., Akhi M.T., Nahaei M.R., Hasani A., Somi M.H., et al. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. J Infect Chemother 2012, 18:848-852.
22. Popovic M., Steinort D., Pillai S., Joukhadar C. Fosfomycin: an old, new friend?. Eur J Clin Microbiol Infect Dis 2010, 29:127-142.
23. Raymond J., Lamarque D., Kalach N., Chaussade S., Burucoa C. High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter 2010, 15:21-27.
24. Suzuki S., Suzuki H., Nishizawa T., Kaneko F., Ootani S., Muraoka H., et al. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori. Digestion 2009, 79:1-4.
25. Valcheva V., Mokrousov I., Rastogi N., Narvskaya O., Markova N. Molecular characterization of Mycobacterium tuberculosis isolates from different regions of Bulgaria. J Clin Microbiol 2008, 46:1014-1018.
26. Vilaichone R.K., Gumnarai P., Ratanachu-Ek T., Mahachai V. Nationwide survey of Helicobacter pylori antibiotic resistance in Thailand. Diagn Microbiol Infect Dis 2013, 77:346-349.
27. Zhang Z., Liu Z.Q., Zheng P.Y., Tang F.A., Yang P.C. Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori. World J Gastroenterol 2010, 16:1279-1284.